OTC Markets OTCPK - Delayed Quote USD

Selectis Health, Inc. (GBCS)

1.5100
0.0000
(0.00%)
At close: May 16 at 4:00:00 PM EDT
Loading Chart for GBCS
  • Previous Close 0.0000
  • Open 2.0000
  • Bid 1.5000 x --
  • Ask 2.2000 x --
  • Day's Range 2.0000 - 2.0000
  • 52 Week Range 1.1200 - 2.5000
  • Volume 1,000
  • Avg. Volume 454
  • Market Cap (intraday) 4.631M
  • Beta (5Y Monthly) -0.42
  • PE Ratio (TTM) --
  • EPS (TTM) -0.8000
  • Earnings Date May 21, 2025 - May 29, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jul 20, 2015
  • 1y Target Est --

Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.

www.selectis.com

616

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GBCS

View More

Performance Overview: GBCS

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

GBCS
34.82%
S&P 500 (^GSPC)
1.30%

1-Year Return

GBCS
39.60%
S&P 500 (^GSPC)
12.48%

3-Year Return

GBCS
71.51%
S&P 500 (^GSPC)
48.66%

5-Year Return

GBCS
11.18%
S&P 500 (^GSPC)
108.07%

Compare To: GBCS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GBCS

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    4.63M

  • Enterprise Value

    36.96M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.12

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.94

  • Enterprise Value/EBITDA

    30.98

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -6.14%

  • Return on Assets (ttm)

    -4.60%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    39.49M

  • Net Income Avi to Common (ttm)

    -2.45M

  • Diluted EPS (ttm)

    -0.8000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    680.33k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -138.3k

Research Analysis: GBCS

View More

Company Insights: GBCS

Research Reports: GBCS

View More

People Also Watch